India, April 21 -- Kazmira Therapeutics has just rolled out 1Cannabis, an online platform aimed at boosting knowledge about prescription cannabinoid therapies for both healthcare providers and patients.
This platform features three organized programs centered around cannabidiol or CBD. First, there's CBD001, a 30-minute course for patients that covers the basics of CBD. Then we have CBD101, a 90-minute program designed for clinicians that dives into cannabinoid science, safety, and how CBD interacts with other drugs.
For those looking for something more in-depth, CBD201 is on the way; it will tackle clinical protocols and tailored treatment strategies.
Pulak Sharma, co-founder and co-CEO of Kazmira, mentioned that this initiative aims to...